Compare ENLV & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | NIU |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.2M | 234.5M |
| IPO Year | 2014 | 2018 |
| Metric | ENLV | NIU |
|---|---|---|
| Price | $0.67 | $2.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $20.00 | $3.50 |
| AVG Volume (30 Days) | 409.3K | ★ 593.8K |
| Earning Date | 05-29-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.54 |
| Revenue Next Year | N/A | $17.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $2.08 |
| 52 Week High | $2.10 | $5.67 |
| Indicator | ENLV | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 38.97 |
| Support Level | $0.66 | $2.08 |
| Resistance Level | $1.23 | $3.24 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 6.44 | 43.69 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.